Gilead offers trade secrets to generic firms to help them make its AIDS drug more cheaply

Get RSS feed of these results

All components of this story

11 August 2006

Student AIDS Activists Applaud Breakthrough in Gilead’s Policies on AIDS Drugs for Global

Author: Matthew Kavanagh, Student Global AIDS Campaign

The Student Global AIDS Campaign (SGAC) is applauding what it calls “important steps forward and major new promises” taken by Gilead in making its AIDS drugs Tenofovir (Viread) and Truvada affordable and available in Africa and the global South. The Student Global AIDS Campaign—a national network of AIDS activists in high schools and colleges—has been running a campaign focused on Gilead since this winter.

Read the full post here

8 August 2006

Gilead Gives Up Trade Secrets to Get AIDS Drugs to Poor Nations

Author: Marni Leff Kottle , Bloomberg News [US}

Gilead Sciences Inc., maker of the world's best-selling AIDS treatment, is offering to help generic-drug makers in India produce the medicine, a move intended to get the life-saving pill to millions more people in the world's poorest countries. Since 2004, Gilead has twice slashed its price for Truvada...Still, only 45,000 to 50,000 of the 6.5 million people in poor countries who need AIDS drugs to stay alive are receiving any of Gilead's medicines. To get the drug to more patients, Gilead is handing over its manufacturing secrets to generic companies who may be able sell the drugs for even less... ``It's a huge change,'' said Helene Gayle, former director of the HIV program at the Bill & Melinda Gates Foundation... ``We just haven't seen this kind of willingness to cooperate before.''...Bristol-Myers Squibb Co. and...Roche...say they are pursuing similar deals... [also refers to Emcure, Aspen Pharmacare, Matrix Laboratories]

Read the full post here